Drug Pipeline

Setidegrasib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
2
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT07566052
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell…		 Recruitment opened
2026-05-19 NCT07409272
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either…		 Trial sites expanded: 13 -> 17 locations
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07409272 A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either… Pancreatic Cancer Recruiting
NCT07566052 A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell… Non-small Cell Lung Cancer (NSCLC) Recruiting
Phase 2
NCT07483983 Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell… Metastatic/Locally Advanced Non-Small-Cell Lung Cancer Recruiting
Phase 1
NCT07395024 A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body… Healthy Volunteer Recruiting
NCT05382559 A Study of ASP3082 in Adults With Advanced Solid Tumors Solid Tumor Recruiting
Sponsors Running Setidegrasib Trials
Astellas Pharma Global Development, Inc. (3) Astellas Pharma Inc (1) Gustave Roussy, Cancer Campus, Grand Paris (1)
Disease Areas
Pancreatic Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2)
Get alerts when Setidegrasib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free